Noel P R, Barnett K C, Davies R E, Jolly D W, Leahy J S, Mawdesley-Thomas L E, Shillam K W, Squires P F, Street A E, Tucker W C, Worden A N
Toxicology. 1975;3(2):143-69. doi: 10.1016/0300-483x(75)90081-5.
Dimethyl sulphoxide (DMSO) was tested for oral toxicity in rats and dogs, and dermal toxicity in rabbits and pigs. Oral administration was by gastric intubation as a 50% equeous solution, 5 days/week at levels equivalent to 9.0, 3.0 or 1.0 ml undiluted DMSO/hg/day. For dermal application 50% and 90% equeous solutions were used to give levels equivalent to 8.1, 4.5, 2.7 or 1.5 ml DMSO/hg/day, as one daily application for rabbits, and divided into two applications/day for pigs. Dogs were dosed for approximately 2 years and pigs for 1 year, although half the animals of both species were dosed for only 18 weeks. Rats were dosed for 18 months, but some were used for interim sacrifice after a year. Rabbits received applications to normal and abraded skin for 6 months. Minor changes in bodyweight and haematological values were observed, together with a physiological diuretic response to DMSO, but the target organ was the eye, principally the lenticular nucleus. Ocular effects in dogs started after 5-10 weeks dosing at 9 ml/kg and consisted of central (nuclear) lens changes with alteration of the refractive index (myopia); transitory equatorial opacities during the 5th month; central (nuclear) opalescence; and changes in the vitreous humour. Similar changes occurred more slowly at 3 ml/kg, the alterations to the vitreous being first observed after 9-10 months at this level. Progressive nuclear refractive changes occurred after dosing for considerably longer than 6 months at 1ml/kg, but none of the animals in this group manifested the opalescence. Biochemical investigation of the lenses revealed reduction of soluble protein (mainly alpha-crystallin), glutathione and water levels, and an increase of insoluble protein. Evidence of recovery was limited mainly to a reduction in the number of dioptres needed to correct nuclear refractive change. Cessation of dosing led to regression of refractive nuclear changes but did not prevent the appearance of opalescence at 3 ml/kg and above. Dogs were the most severely affected of the 4 species, with nuclear effects at 1ml/kg, extensive changes in the lens, and involvement of the vitreous. Pigs and rabbits were affected by dose levels of 2.7 ml/kg and 1.5 ml/kg respectively. Rats occasionally showed minimal changes at 9 ml/kg. The importance of the findings in dogs is discussed in relation to general toxicological protocols. It is emphasised that reversibility of signs, and adequate duration of administration, must both be considered when ascertaining whether changes occur at levels approximating to those of human intake.
对大鼠和狗进行了二甲基亚砜(DMSO)的经口毒性试验,对兔子和猪进行了皮肤毒性试验。经口给药采用胃插管方式,使用50%的水溶液,每周给药5天,剂量相当于9.0、3.0或1.0毫升未稀释的DMSO/千克/天。皮肤给药时,使用50%和90%的水溶液,剂量相当于8.1、4.5、2.7或1.5毫升DMSO/千克/天,兔子每天给药一次,猪每天分两次给药。狗给药约2年,猪给药1年,不过这两个物种各有一半动物仅给药18周。大鼠给药18个月,但有些在给药1年后用于中期处死。兔子在正常皮肤和破损皮肤上给药6个月。观察到体重和血液学值有轻微变化,以及对DMSO的生理性利尿反应,但靶器官是眼睛,主要是晶状体核。狗在以9毫升/千克给药5 - 10周后开始出现眼部效应,包括晶状体中央(核)变化及折射率改变(近视);第5个月出现短暂的赤道部混浊;晶状体中央(核)呈乳白色;以及玻璃体变化。在3毫升/千克时,类似变化出现得较慢,在此剂量水平下,9 - 10个月后首次观察到玻璃体改变。在1毫升/千克给药超过6个月后出现渐进性核折射率变化,但该组动物均未出现晶状体乳白色混浊。晶状体的生化研究显示可溶性蛋白(主要是α - 晶状体蛋白)、谷胱甘肽和水分含量减少,不溶性蛋白增加。恢复的证据主要限于校正核折射率变化所需屈光度的减少。停止给药导致核折射率变化消退,但不能防止在3毫升/千克及以上剂量时出现晶状体乳白色混浊。在这4个物种中,狗受影响最严重,在1毫升/千克时出现核效应,晶状体有广泛变化,且玻璃体也受到影响。猪和兔子分别在2.7毫升/千克和1.5毫升/千克的剂量水平受到影响。大鼠在9毫升/千克时偶尔出现极小变化。结合一般毒理学方案讨论了狗的研究结果的重要性。强调在确定在接近人类摄入量的水平是否发生变化时,必须同时考虑体征的可逆性和足够的给药持续时间。